Copy Link Print Information

Rontalizumab

(Synonyms: RhuMab IFNalpha; Anti-Human IFN alpha Recombinant Antibody)
Customer Review

Based on 1 Customer Validation

Rontalizumab is a humanized IgG1 monoclonal antibody targets IFN-α. Rontalizumab can be used for the research of systemic lupus erythematosus[1].

For research use only. We do not sell to patients.

  • Purity: 99.08%
  • CAS No.: 948570-30-7
  • Molecular Weight:146.18 kDa
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Rontalizumab
  • Experimental Validation Results for Rontalizumab
  • Rontalizumab Chemical Structure
    Rontalizumab Chemical Structure
CAS No.: 948570-30-7
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Rontalizumab Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
Top Publications Citing

Use of MCE Products
Keywords
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Register
Sign in to MedChemExpress
Register New Account

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    Human IgG1 kappa

  • 1/16

    Immobilized IFN-alpha 1/IFNA13 Protein, Human (HEK293, His, HY-P70241) can bind Rontalizumab. The EC50 for this effect is 3.293 ng/mL.

  • Rontalizumab Chemical Structure
    1/16
  • Rontalizumab
  • Immobilized IFN-alpha 1/IFNA13 Protein, Human (HEK293, His, HY-P70241) can bind Rontalizumab. The EC50 for this effect is 3.293 ng/mL.